On October 18, 2013, the Bard LifeStent Solo Vascular Stent was FDA recalled. The FDA notified health care professionals and medical care organizations of a class 1 recall of the Bard LifeStent Solo Vascular Stent due to a failure to deploy.
The LifeStent Solo Vascular Stent is an implantable self-expanding stent and delivery system used to improve the inner open space of a blood vessel (luminal diameter) in the treatment of lesions caused by the abnormal narrowing in a blood vessel (symptomatic de-novo or restenotic lesions). The affected products were manufactured and distributed from November 2011 to June 13, 2012.
FDA notified health professionals and medical care organizations of a class 1 recall of this product due to deployment issues that range from failure to deploy, partial deployment, and difficult deployment. This product may cause serious adverse health consequences, including possible complications of bleeding, loss of limb, heart attack (myocardial infarction), stroke, vascular surgery, and/or death.
Class I recall: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
If you’ve had the Bard LifeStent Solo Vascular Stent surgically implanted, then you may entitled to financial compensation. Carey Danis & Lowe is looking into Bard LifeStent Solo Vascular Stent lawsuit settlements for individuals who have been implanted with this medical device.
If you or someone you love has undergone this procedure and has been implanted with the Bard LifeStent Solo Vascular Stent, please contact our firm to speak to an attorney or nurse about your case.
Please fill out our online claims form or call 1.800.721.2519 for more information about filing your case.